<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701038</url>
  </required_header>
  <id_info>
    <org_study_id>2005H0186</org_study_id>
    <nct_id>NCT00701038</nct_id>
  </id_info>
  <brief_title>Diagnosis and Treatment of Sleep Apnea in the Acute Exacerbation of Heart Failure</brief_title>
  <official_title>The Role of Diagnosis and Treatment of Sleep Apnea in the Acute Exacerbation of Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rami Khayat</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congestive heart failure affects 2.3 percent of the population (approximately 4,900,000) with
      an incidence of 10 per 1,000 of the population after the age of 65 (1). The admission rate
      for patients with heart failure is on the rise, so is the mortality associated with it and
      its national annual bill, now exceeding $21 billion (1). Obstructive Sleep Apnea (OSA) is
      present in 11-37 percent of patients with heart failure (2,3), and tends to increase in
      severity when the heart failure is less controlled (4, 5). Therefore, the actual prevalence
      of OSA in patients hospitalized with acute heart failure is likely higher. There is now
      evidence that treatment of OSA with nasal Continuous Positive Pressure (nCPAP) in outpatients
      with stable heart failure improves left ventricular ejection fraction, and quality of life
      (6), and confers a reduction in fatal and non-fatal cardiovascular events (7). However, there
      has not been any evaluation of the role of diagnosis and treatment of OSA in patients
      hospitalized with acute heart failure. This uncertainty about the true prevalence and role of
      OSA in exacerbations of heart failure, and the role of its treatment in the acute setting may
      explain why aggressive diagnostic and therapeutic strategy for OSA in patients admitted to
      the hospital with acute heart failure is not part of the standard clinical practice in acute
      care centers. Given the rising admission rate, and mortality associated with heart failure,
      an evaluation of the role of OSA and its treatment in this patient population is highly
      significant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OSA is associated with large negative swings in the intrathoracic pressure, significant
      increase in the sympathetic nerve activity and repetitive surges in blood pressure, along
      with episodic hypoxia and hypercapnea (8, 9). These autonomic and respiratory changes may
      increase the cardiac muscle workload, cardiac dysrrhythmia, and exacerbate ischemia
      (10,11,12). Treatment with continuous positive airway pressure (CPAP) is the most successful
      therapeutic modality available for obstructive sleep apnea. It is still not clear whether
      establishing the diagnosis of OSA and initiating treatment with CPAP while still in the
      hospital carries any benefit in the management of patients with acute heart failure. This
      study will evaluate the effect of work up and treatment of OSA on the outcome of patients
      hospitalized with acute congestive heart failure (CHF).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Ejection Fraction Improvement</measure>
    <time_frame>baseline and again after three nights in hospital</time_frame>
    <description>Left ventricular function was assessed using doppler ultrasound. Positive increase in left ventricular function from baseline to 3 nights post treatment indicates potential beneficial impact of treatment on heart function.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provided with an auto adjusting bi-level positive airway pressure device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>auto adjusting bi-level positive airway pressure device</intervention_name>
    <description>auto adjusting bi-level positive airway pressure device is provided for treatment of obstructive sleep apnea.</description>
    <arm_group_label>Device</arm_group_label>
    <other_name>APAP</other_name>
    <other_name>CPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        .Inclusion Criteria:

          -  Able to provide an informed consent

          -  Speaks English

          -  Older than 21

          -  Heart Failure

          -  Positive for OSA

        Exclusion Criteria:

          -  CSA

          -  Already on CPAP

          -  Hemodynamic instability

          -  Acute respiratory failure

          -  Neurological defect

          -  Dialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rami N Khayat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <reference>
    <citation>Heart Disease and Stroke-Statistics, American Heart Association, 2005 update</citation>
  </reference>
  <reference>
    <citation>Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998 Jun 2;97(21):2154-9.</citation>
    <PMID>9626176</PMID>
  </reference>
  <reference>
    <citation>Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999 Oct;160(4):1101-6.</citation>
    <PMID>10508793</PMID>
  </reference>
  <reference>
    <citation>Skinner MA, Choudhury MS, Homan SD, Cowan JO, Wilkins GT, Taylor DR. Accuracy of monitoring for sleep-related breathing disorders in the coronary care unit. Chest. 2005 Jan;127(1):66-71.</citation>
    <PMID>15653964</PMID>
  </reference>
  <reference>
    <citation>Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation. 1999 Mar 30;99(12):1574-9.</citation>
    <PMID>10096933</PMID>
  </reference>
  <reference>
    <citation>Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004 Feb 1;169(3):361-6. Epub 2003 Nov 3.</citation>
    <PMID>14597482</PMID>
  </reference>
  <reference>
    <citation>Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53.</citation>
    <PMID>15781100</PMID>
  </reference>
  <reference>
    <citation>Katragadda S, Xie A, Puleo D, Skatrud JB, Morgan BJ. Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol (1985). 1997 Dec;83(6):2048-54.</citation>
    <PMID>9390980</PMID>
  </reference>
  <reference>
    <citation>Morgan BJ, Denahan T, Ebert TJ. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol (1985). 1993 Jun;74(6):2969-75.</citation>
    <PMID>8365996</PMID>
  </reference>
  <reference>
    <citation>Magder SA, Lichtenstein S, Adelman AG. Effect of negative pleural pressure on left ventricular hemodynamics. Am J Cardiol. 1983 Sep 1;52(5):588-93.</citation>
    <PMID>6613883</PMID>
  </reference>
  <reference>
    <citation>Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol (1985). 1992 Feb;72(2):583-9.</citation>
    <PMID>1559936</PMID>
  </reference>
  <reference>
    <citation>Hanly P, Sasson Z, Zuberi N, Lunn K. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol. 1993 Jun 1;71(15):1341-5.</citation>
    <PMID>8498378</PMID>
  </reference>
  <reference>
    <citation>Roebuck T, Solin P, Kaye DM, Bergin P, Bailey M, Naughton MT. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J. 2004 May;23(5):735-40.</citation>
    <PMID>15176689</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2008</study_first_submitted>
  <study_first_submitted_qc>June 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <results_first_submitted>August 12, 2011</results_first_submitted>
  <results_first_submitted_qc>November 9, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 14, 2011</results_first_posted>
  <last_update_submitted>January 29, 2013</last_update_submitted>
  <last_update_submitted_qc>January 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Rami Khayat</investigator_full_name>
    <investigator_title>Associate Professor-Clinical</investigator_title>
  </responsible_party>
  <keyword>Sleep apnea,</keyword>
  <keyword>obstructive sleep apnea,</keyword>
  <keyword>heart failure,</keyword>
  <keyword>CHF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Device</title>
          <description>Provided with an auto adjusting bi-level positive airway pressure device for 3 days in hospital</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>No auto adjusting bi-level positive airway pressure device given during hospital stay</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>study amended pilot group of patients</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Device</title>
          <description>Provided with an auto adjusting bi-level positive airway pressure device for 3 days in hospital</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>No auto adjusting bi-level positive airway pressure device given during hospital stay</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="54"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="14"/>
                    <measurement group_id="B2" value="51" spread="12"/>
                    <measurement group_id="B3" value="56" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Left Ventricular Ejection Fraction Improvement</title>
        <description>Left ventricular function was assessed using doppler ultrasound. Positive increase in left ventricular function from baseline to 3 nights post treatment indicates potential beneficial impact of treatment on heart function.</description>
        <time_frame>baseline and again after three nights in hospital</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Device</title>
            <description>Provided with an auto adjusting bi-level positive airway pressure device for 3 days in hospital</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No auto adjusting bi-level positive airway pressure device given during hospital stay</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Ejection Fraction Improvement</title>
          <description>Left ventricular function was assessed using doppler ultrasound. Positive increase in left ventricular function from baseline to 3 nights post treatment indicates potential beneficial impact of treatment on heart function.</description>
          <population>ITT</population>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="1.7"/>
                    <measurement group_id="O2" value="-.3" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Device</title>
          <description>Provided with an auto adjusting bi-level positive airway pressure device for 3 days in hospital</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>No auto adjusting bi-level positive airway pressure device given during hospital stay</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rami Khayat</name_or_title>
      <organization>The Ohio State Universtiy</organization>
      <phone>614-247-7707</phone>
      <email>rami.khayat@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

